Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/07/2023 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 55.3k | $58.79 | $3.3M | | 08/07/2023 |
08/07/2023 | Intra-Cellular Therapies, Inc. | ITCI | Exercise | Stock Option (right to buy) | 55.3k | $18.59 | $1M | | 08/07/2023 |
03/13/2023 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 3.3k | $45.10 | $150.4k | | 03/09/2023 |
03/13/2023 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 423 | $44.05 | $18.6k | | 03/09/2023 |
03/10/2023 | Intra-Cellular Therapies, Inc. | ITCI | Exercise | Restricted Stock Units | 7.3k | $0.00 | $0 | | 03/09/2023 |
03/10/2023 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 6.8k | $43.50 | $293.6k | | 03/09/2023 |
03/10/2023 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 1.8k | $42.74 | $76.9k | | 03/09/2023 |
03/09/2023 | Intra-Cellular Therapies, Inc. | ITCI | Grant | Common Stock | 16.7k | $0.00 | $0 | | 03/09/2023 |
03/06/2023 | Intra-Cellular Therapies, Inc. | ITCI | Grant | Restricted Stock Units | 39.4k | $0.00 | $0 | | 03/06/2023 |
03/01/2023 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 7.2k | $50.01 | $362.1k | | 03/01/2023 |
02/24/2023 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 4k | $47.12 | $190.6k | | 02/23/2023 |
02/23/2023 | Intra-Cellular Therapies, Inc. | ITCI | Exercise | Restricted Stock Units | 7.9k | $0.00 | $0 | | 02/23/2023 |
02/21/2023 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 635 | $48.93 | $31.1k | | 02/18/2023 |
02/21/2023 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 123 | $47.32 | $5.8k | | 02/18/2023 |
02/21/2023 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 3.1k | $46.61 | $146.4k | | 02/18/2023 |
02/18/2023 | Intra-Cellular Therapies, Inc. | ITCI | Exercise | Restricted Stock Units | 11.1k | $0.00 | $0 | | 02/18/2023 |
04/08/2022 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 17.5k | $63.55 | $1.1M | | 04/08/2022 |
04/08/2022 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 54k | $64.42 | $3.5M | | 04/08/2022 |
04/08/2022 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 14.9k | $65.14 | $969.6k | | 04/08/2022 |
04/08/2022 | Intra-Cellular Therapies, Inc. | ITCI | Exercise | Stock Option (right to buy) | 86.3k | $12.73 | $1.1M | | 04/08/2022 |
03/10/2022 | Intra-Cellular Therapies, Inc. | ITCI | Grant | Restricted Stock Units | 22k | $0.00 | $0 | | 03/10/2022 |
03/10/2022 | Intra-Cellular Therapies, Inc. | ITCI | Grant | Stock Option (right to buy) | 17.9k | $56.73 | $1M | | 03/10/2022 |
02/24/2022 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 2.7k | $52.94 | $140.8k | | 02/23/2022 |
02/24/2022 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 3.9k | $52.03 | $201.6k | | 02/23/2022 |
02/24/2022 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 1.4k | $51.33 | $70.4k | | 02/23/2022 |
02/23/2022 | Intra-Cellular Therapies, Inc. | ITCI | Exercise | Restricted Stock Units | 7.9k | $0.00 | $0 | | 02/23/2022 |
02/22/2022 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 6.5k | $55.60 | $363.2k | | 02/18/2022 |
02/22/2022 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 4.6k | $54.84 | $252.6k | | 02/18/2022 |
02/18/2022 | Intra-Cellular Therapies, Inc. | ITCI | Exercise | Restricted Stock Units | 11.1k | $0.00 | $0 | | 02/18/2022 |
01/10/2022 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 4.3k | $40.09 | $170.5k | | 01/08/2022 |
01/10/2022 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 13.9k | $40.80 | $568.5k | | 01/08/2022 |
01/10/2022 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 2.8k | $41.74 | $115.2k | | 01/08/2022 |
01/08/2022 | Intra-Cellular Therapies, Inc. | ITCI | Exercise | Restricted Stock Units | 20.9k | $0.00 | $0 | | 01/08/2022 |
10/18/2021 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 6.7k | $41.49 | $278.1k | | 10/15/2021 |
10/18/2021 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 4.3k | $40.77 | $174.8k | | 10/15/2021 |
|